Correlation Between Seer and AN2 Therapeutics

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Seer and AN2 Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Seer and AN2 Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Seer Inc and AN2 Therapeutics, you can compare the effects of market volatilities on Seer and AN2 Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Seer with a short position of AN2 Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Seer and AN2 Therapeutics.

Diversification Opportunities for Seer and AN2 Therapeutics

0.76
  Correlation Coefficient

Poor diversification

The 3 months correlation between Seer and AN2 is 0.76. Overlapping area represents the amount of risk that can be diversified away by holding Seer Inc and AN2 Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on AN2 Therapeutics and Seer is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Seer Inc are associated (or correlated) with AN2 Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of AN2 Therapeutics has no effect on the direction of Seer i.e., Seer and AN2 Therapeutics go up and down completely randomly.

Pair Corralation between Seer and AN2 Therapeutics

Given the investment horizon of 90 days Seer Inc is expected to generate 0.62 times more return on investment than AN2 Therapeutics. However, Seer Inc is 1.61 times less risky than AN2 Therapeutics. It trades about 0.16 of its potential returns per unit of risk. AN2 Therapeutics is currently generating about 0.1 per unit of risk. If you would invest  177.00  in Seer Inc on September 18, 2024 and sell it today you would earn a total of  57.00  from holding Seer Inc or generate 32.2% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthSignificant
Accuracy100.0%
ValuesDaily Returns

Seer Inc  vs.  AN2 Therapeutics

 Performance 
       Timeline  
Seer Inc 

Risk-Adjusted Performance

12 of 100

 
Weak
 
Strong
Good
Compared to the overall equity markets, risk-adjusted returns on investments in Seer Inc are ranked lower than 12 (%) of all global equities and portfolios over the last 90 days. Even with relatively unsteady technical and fundamental indicators, Seer reported solid returns over the last few months and may actually be approaching a breakup point.
AN2 Therapeutics 

Risk-Adjusted Performance

7 of 100

 
Weak
 
Strong
OK
Compared to the overall equity markets, risk-adjusted returns on investments in AN2 Therapeutics are ranked lower than 7 (%) of all global equities and portfolios over the last 90 days. In spite of fairly inconsistent basic indicators, AN2 Therapeutics showed solid returns over the last few months and may actually be approaching a breakup point.

Seer and AN2 Therapeutics Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Seer and AN2 Therapeutics

The main advantage of trading using opposite Seer and AN2 Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Seer position performs unexpectedly, AN2 Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in AN2 Therapeutics will offset losses from the drop in AN2 Therapeutics' long position.
The idea behind Seer Inc and AN2 Therapeutics pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Sync Your Broker module to sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors..

Other Complementary Tools

ETF Categories
List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments
Transaction History
View history of all your transactions and understand their impact on performance
Analyst Advice
Analyst recommendations and target price estimates broken down by several categories
Equity Forecasting
Use basic forecasting models to generate price predictions and determine price momentum
Companies Directory
Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals